Thros H, Sigurdsson H, Oddsson E, Bjodleifsson B
Medicinsk avd, Lanspitalinn, Reykjavik.
Nord Med. 1994;109(4):117-20.
In Iceland, the consumption of pharmaceutics for lesions of the gastrointestinal tract is 20 DDD/1,000 inhabitant days, which is 2-3 times more than that of any of the other Nordic countries. A nationwide investigation showed 1.54 per cent of the Icelandic population to be on continuous ulcer medication, consumption being greatest in the 70-79-year-old age group. H2-blockers are used in 79 per cent of cases, omeprazole in 17 per cent, and other drugs in 4 per cent. Of the prescriptions, 65 per cent were issued by GPs, 15 per cent by gastro-enterologists and 14 per cent by other categories of physicians, the remaining 6 per cent being issued at hospitals. The reasons given by patients for the medication were ulcer problems (30 per cent), heartburn (29 per cent), gastritis (21 per cent), dyspepsia (9 per cent), and side-effects of other medication (7 per cent).
在冰岛，用于治疗胃肠道疾病的药物消费量为每1000居民日20限定日剂量，这比其他任何北欧国家都高出2至3倍。一项全国性调查显示，冰岛有1.54%的人口在持续服用治疗溃疡的药物，70至79岁年龄组的消费量最大。79%的病例使用H2受体阻滞剂，17%使用奥美拉唑，4%使用其他药物。在这些处方中，65%由全科医生开具，15%由胃肠病学家开具，14%由其他科医生开具，其余6%在医院开具。患者服用药物的原因是溃疡问题（30%）、胃灼热（29%）、胃炎（21%）、消化不良（9%）以及其他药物的副作用（7%）。
